The Federal Act on Medically Assisted Reproduction (Reproductive Medicine Act – RMA) came into force on 1 January 2001. It allows us to offer care using the most modern MAR techniques.
Our unit has an ISO 9001:2015 certificate and our laboratory is accredited to ISO 15189:2013. This provides a guarantee of excellence of the treatments we offer you.
The major provisions of the RMA:
- The couple must be able to raise the child until his/her majority.
- Any treatment requires consent by both partners.
- Psychological support must be offered before, during and after the treatment.
- The culture of embryos is authorised during a treatment cycle up to the 5th or 6th day of development.
- The cryopreservation of embryos is authorised for a maximum period of 10 years.
- Only a married couple can benefit from sperm donation.
- Sperm donation is not anonymous: at 18 years of age the child can obtain information about the donor's identity from the Office de l’état civil (Civil Services Centre).
In particular, the RMA forbids:
- determination of sex (except to exclude a serious disease)
- egg cell donation
- surrogate motherhood
Changes introduced with the revision of the RMA
From 1 September 2017, important changes have allowed couples to maximise their chances of becoming a parent
These changes include:
- The number of embryos that can be developed during a treatment cycle increases from three to 12.
- Unused embryos can be frozen with a view to later treatment for a duration of five years, renewable on request (maximum duration of 10 years).
- Preimplantation genetic diagnosis (PGD) is authorised*.
*PGD is a procedure that is authorised in two cases: only couples carrying a severe hereditary disease (preimplantation diagnosis) and couples who cannot reproduce naturally can decide to have this examination (preimplantation genetic screening).